GDA: Enzyme Plays A Vital Role in DNA Replication and Gene Expression

Target Name: GDA

NCBI ID: G9615

Content of Review Report on GDA Target / Biomarker

GDA

GDA: Enzyme Plays A Vital Role in DNA Replication and Gene Expression

Guanine Deaminase (GDA) is a protein that is found in all living cells. It is a crucial enzyme that plays a vital role in the process of DNA replication and repair. GDA is also involved in the regulation of gene expression and can be regulated by various factors in the cell.

GDA is a protein that is composed of two subunits, GDA1 and GDA2. GDA1 is the primary subunit and is responsible for the catalytic activity of GDA. GDA2 is a smaller subunit that plays a structural role in the protein.

GDA is involved in the process of DNA replication and repair. During DNA replication, GDA helps to ensure that the new DNA strand is synthesized correctly. It does this by catalyzing the transfer of a nitrogenous base (an amino acid) to the growing chain. This process is essential for the development and growth of all living organisms.

GDA is also involved in the regulation of gene expression. It can bind to specific DNA sequences and prevent the binding of other transcription factors. This allows GDA to regulate the level of gene expression in the cell.

GDA can also be regulated by various factors in the cell. For example, the level of GDA can be increased or decreased by the addition of certain drugs or by changes in the cell's environment. This allows researchers to use GDA as a drug target or biomarker for various diseases.

One of the most promising applications of GDA as a drug target is the treatment of cancer. GDA has been shown to be involved in the development and progression of many types of cancer. For example, studies have shown that high levels of GDA are associated with the development of certain types of cancer. Additionally, inhibitors of GDA have been shown to be effective in treating certain types of cancer.

Another promising application of GDA as a biomarker is its use in the diagnosis and monitoring of certain diseases. For example, GDA has been shown to be involved in the development and progression of a number of diseases, including cancer. By measuring the level of GDA in a patient's body, researchers can monitor the effectiveness of a treatment and determine if it is having the desired effect.

GDA is also an important protein that is involved in the regulation of many other cellular processes. It is a key regulator of cell division, cell growth, and the development of new tissues. It is also involved in the regulation of cell signaling and can interact with a wide variety of molecules in the cell.

In conclusion, GDA is a protein that is involved in many important cellular processes. It is a crucial enzyme that plays a vital role in the process of DNA replication and repair. GDA is also involved in the regulation of gene expression and can be regulated by various factors in the cell. Its role in these processes makes it an attractive target for the development of new drugs and biomarkers for a wide variety of diseases.

Protein Name: Guanine Deaminase

Functions: Catalyzes the hydrolytic deamination of guanine, producing xanthine and ammonia

The "GDA Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GDA comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets